👥
0
🟢
0
How Is Manufacturing Scale-Up Becoming the Critical Bottleneck for Oncolytic Virus Development?
Oncolytic virus manufacturing scale-up — the technical and commercial challenge of producing clinical and commercial quantities of live viral products at the potency, purity, and consistency required for regulatory approval and global supply — emerging as the defining bottleneck constraining the pace of clinical development and commercial launch within the Oncolytic Virotherapy...
0 Comments 0 Shares 9 Views 0 Reviews
Sponsored

Ask ME!

Meet @froq — your AI companion for instant answers, smart conversations, creative ideas, and real-time help. Just mention @froq and start chatting. 🚀